Le Lézard
Classified in: Health, Business
Subjects: ECO, RTG

/R E P E A T -- Canopy Growth to Trade as WEED on the TSX/


Company to Celebrate with Market Opening Bell Ringing Ceremony

SMITHS FALLS, ON, Jan. 31, 2017 /CNW/ - Canopy Growth Corporation (TSX: CGC) ("Canopy Growth" or "the Company") is pleased to announce that its share ticker will change to TSX:WEED upon the commencement of trading on the Toronto Stock Exchange ("TSX") on February 1, 2017.

"Patients, investors and Canadians as a whole are more accepting of the cannabis sector today than ever before," said Bruce Linton, Chairman and CEO of Canopy Growth. "This is owed to a lot of factors, but we are proud to have played our part in introducing a once-stigmatized topic into Main Street and Bay Street conversations. From our beginnings in an abandoned chocolate factory, to our funding of research to our countless doctor interactions, we have always taken pride in putting people at ease to open the door to a more meaningful conversation. Now, over three years later, we're thrilled to be marketing WEED on Bay Street."

The ticker symbol change comes at a transformative time for Canopy Growth. On January 27th, 2017, shareholders voted overwhelmingly in favour of a previously announced acquisition of Mettrum Health Corp. All conditions of an arrangement agreement dated November 30, 2016, as amended, and previously announced by the Companies on December 1, 2016 have been met and the transaction is now officially closed. With Mettrum under the canopy, the Company has created the largest legal cannabis business in the world. Moving forward this means additional production capacity, physician outreach opportunities, research, jobs and economic stimulus across Ontario and Canada.

With a strong portfolio of diverse national brands, unparalleled diversified production capacity, and a strong financial position, Canopy Growth is poised to continue its growth trajectory to meet the demand of domestic and international cannabis markets.

Canopy Growth team members from across the country will "ring the bell" to open trading on the TSX on February 1, 2017. The CGC team is looking forward to celebrating the acquisition of Mettrum, a new ticker, and is looking forward to continued Future Growth.

Watch it here in real time here https://www.youtube.com/watch?v=DGUI5rWwLMo or on BNN television.

An archive of the ceremony will also be made available at http://www.tsx.com/news/market-opens.

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms.  Through its wholly?owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over 650k square feet of indoor and greenhouse production capacity.  Canopy Growth has established partnerships with leading sector names in Canada and abroad.  For more information visit www.canopygrowth.com.

Notice Regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation and its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection.  The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

SOURCE Canopy Growth Corporation


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: